...
首页> 外文期刊>Molecular Metabolism >Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT
【24h】

Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT

机译:通过FFAR4 / GPR120在Wat中的Nefas感测脂肪分析的自分泌负反馈调节

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives Long-chain fatty acids (LCFAs) released from adipocytes inhibit lipolysis through an unclear mechanism. We hypothesized that the LCFA receptor, FFAR4 (GPR120), which is highly expressed in adipocytes, may be involved in this feedback regulation. Methods and results Liquid chromatography mass spectrometry (LC-MS) analysis of conditioned media from isoproterenol-stimulated primary cultures of murine and human adipocytes demonstrated that most of the released non-esterified free fatty acids (NEFAs) are known agonists for FFAR4. In agreement with this, conditioned medium from isoproterenol-treated adipocytes stimulated signaling strongly in FFAR4 transfected COS-7 cells as opposed to non-transfected control cells. In transfected 3T3-L1 cells, FFAR4 agonism stimulated Gi- and Go-mini G protein binding more strongly than Gq, effects which were blocked by the selective FFAR4 antagonist AH7614. In primary cultures of murine white adipocytes, the synthetic, selective FFAR4 agonist CpdA inhibited isoproterenol-induced intracellular cAMP accumulation in a manner similar to the antilipolytic control agent nicotinic acid acting through another receptor, HCAR2. In?vivo , oral gavage with the synthetic, specific FFAR4 agonist CpdB decreased the level of circulating NEFAs in fasting lean mice to a similar degree as nicotinic acid. In agreement with the identified anti-lipolytic effect of FFAR4, plasma NEFAs and glycerol were increased in FFAR4-deficient mice as compared to littermate controls despite having elevated insulin levels, and cAMP accumulation in primary adipocyte cultures was augmented by treatment with the FFAR4 antagonist conceivably by blocking the stimulatory tone of endogenous NEFAs on FFAR4. Conclusions In white adipocytes, FFAR4 functions as an NEFA-activated, autocrine, negative feedback regulator of lipolysis by decreasing cAMP though Gi-mediated signaling.
机译:目的通过adipocytes释放的长链脂肪酸(LCFA)通过不明确的机制抑制脂解。我们假设LCFA受体,在脂肪细胞中高度表达的LCFA受体FFAR4(GPR120)可参与该反馈调控。方法和结果液相色谱质谱(LC-MS)分析来自异丙肾上腺素刺激的鼠和人脂肪细胞的原发性培养基的分析证明,大多数释放的非酯化游离脂肪酸(Nefas)是FFAR4的已知激动剂。与此,来自异丙肾上腺素处理的脂肪细胞的调节培养基,其在FFAR4转染的COS-7细胞中强烈地刺激信号,而不是未转染的对照细胞。在转染的3T3-L1细胞,FFAR4激动刺激GI-和GO-迷你G蛋白比的Gq更强烈结合,这阻断了通过选择性FFAR4拮抗剂AH7614的效果。在鼠白色脂肪细胞的原代培养物中,合成的选择性FFAR4激动剂CPDA以类似于通过另一受体,HCAR2作用的脱抗冰醇对照剂烟酸烟酸的方式抑制异戊二醇诱导的细胞内阵营积累。在α体内,口服饲养与合成的,特定的FFAR4激动剂CpdB在将瘦小鼠中循环Nefas的水平降低到与烟酸相似的程度。与FFAR4的所识别的抗脂肪分解效果协议,等离子体NEFAs和甘油相比于同窝对照在FFAR4缺陷小鼠分别提高,尽管有胰岛素水平升高,和cAMP积累在初级脂肪细胞培养物中通过与FFAR4拮抗剂可以想象治疗增强通过阻断FFAR4上内源性Nefas的刺激性调。结论在白色脂肪细胞中,FFAR4通过降低CAMP作为NEFA活化的,自分泌,负反馈调节器,尽管GI介导的信号传导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号